IART - インテグラ・ライフサイエンシズ・ホ―ルディングス （Integra LifeSciences Holdings Corporation）

ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed the Russell 2500 Growth benchmark. On an absolute basis, the strategy gained in nine of the 10 sectors it was invested in […]

Integra''s fourth quarter results were in-line but still lackluster, with just 3% organic revenue growth. Click here to see our take on IART stock.

https://www.investing.com/news/pro/integra-lifesciences-pt-raised-to-55-at-piper-sandler-432SI-3011819

https://www.investing.com/news/assorted/integra-lifesciences-files-mixed-shelf-432SI-3011373

Integra LifeSciences Holdings Corporation (NASDAQ:NASDAQ:IART) Q4 2022 Earnings Conference Call February 22, 2023 8:30 AM ETCompany ParticipantsChris Ward - Senior Director, Investor…

Integra''s fourth quarter results were in-line but still lackluster, with just 3% organic revenue growth. Click here to see our take on IART stock.

https://www.investing.com/news/pro/integra-lifesciences-pt-raised-to-55-at-piper-sandler-432SI-3011819

https://www.investing.com/news/assorted/integra-lifesciences-files-mixed-shelf-432SI-3011373

Integra LifeSciences Holdings Corporation (NASDAQ:NASDAQ:IART) Q4 2022 Earnings Conference Call February 22, 2023 8:30 AM ETCompany ParticipantsChris Ward - Senior Director, Investor…

The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with their 2022 Q4 earnings call.

PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 41st Annual J.P. Morgan Healthcare conference on January 11, 2023 at 7:30pm ET.

In 2022, Mentor Worldwide LLC (Johnson & Johnson) received the US FDA approved a new MENTOR Memory Gel boost breast implant Northbrook, IL 60062 -- ( SBWIRE ) -- 12/16/2022 -- According to the global research report " Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026", published by MarketsandMarkets™, The global breast reconstruction market size is expected to reach USD 647 million by 2026 from USD 567 million in 2021, at a CAGR of 2.7%. The growth in this market is driven by the increasing number of breast reconstruction surgeries and rising incidences of breast cancer. Browse in-depth TOC on "Breast Reconstruction Market" 292 – Tables 45 – Figures 252 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593 The rising incidence of breast cancer and the availability of reimbursement for breast reconstruction are major driving factors for the market.

Major players in the surgical retractors market are B. Braun, Becton, Dickinson and Company, Henry Schein Inc. , Integra Lifesciences Holdings Corporation, Johnson & Johnson Private Limited, Medline Industries Inc. Major players in the surgical retractors market are B. Braun, Becton, Dickinson and Company, Henry Schein Inc. , Integra Lifesciences Holdings Corporation, Johnson & Johnson Private Limited, Medline Industries Inc.

The study provides an in-depth analysis of the major market players in the Enzymatic Wound Debridement market. It provides a detailed analysis of each segment and driving factors coupled with growth rate analysis. Furthermore, the report also provides regional analysis

CereLink overhang largely removed, with the company actively providing an intermediate solution to customers. Click here to read our analysis of IART stock.